Cetera Advisors’s ResMed RMD Stock Holding History

Cetera Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$257K	Buy	+1,300	New	+$238K	﹤0.01%	2048
2023 Q3	–	Sell	-1,908	Closed	-$417K	–	1781
2023 Q2	$417K	Sell	1,908 -98	-5%	-$21.8K	0.01%	1150
2023 Q1	$439K	Sell	2,006 -554	-22%	-$120K	0.01%	1082
2022 Q4	$533K	Buy	2,560 +1,584	+162%	+$348K	0.01%	944
2022 Q3	$213K	Buy	976 +21	+2%	+$4.78K	0.01%	1110
2022 Q2	$200K	Sell	955 -400	-30%	-$85.2K	﹤0.01%	1245
2022 Q1	$329K	Buy	1,355 +4	+0.3%	+$968	0.01%	1067
2021 Q4	$352K	Hold	1,351	–	–	0.01%	1048
2021 Q3	$356K	Hold	1,351	–	–	0.01%	1021
2021 Q2	$333K	Buy	1,351 +250	+23%	+$52.6K	0.01%	1003
2021 Q1	$214K	Buy	+1,101	New	+$221K	0.01%	1118
2019 Q1	–	Sell	-2,140	Closed	-$245K	–	1272
2018 Q4	$245K	Buy	+2,140	New	+$229K	0.01%	695

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Advisors's RMD Position: Q1 2024 in Review

Cetera Advisors opened a new position in ResMed (RMD) in Q1 2024: 1,300 shares worth $257K. The stake represents ﹤0.01% of the portfolio and ranks #2048 among its holdings. This is a return to the name: Cetera Advisors previously reported a position in RMD as recently as Q2 2023.

Cetera Advisors first reported a position in RMD in Q4 2018 and has held it in 12 quarters since. The position peaked at $533K in Q4 2022. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

Cetera Advisors held 1,300 shares of ResMed worth $257K as of Q1 2024.
ResMed was a new Cetera Advisors position in Q1 2024.
ResMed made up ﹤0.01% of Cetera Advisors's portfolio in Q1 2024, its #2048 holding.
Cetera Advisors first reported a position in ResMed in Q4 2018 and has held it in 12 quarters since.
Cetera Advisors's ResMed position peaked at $533K in Q4 2022.
718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.